Mini-review: Foldosome regulation of androgen receptor action in prostate cancer

Laia Querol Cano1, Derek N Lavery, Charlotte L Bevan

  • 1Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom.

Insights

The foldosome, crucial for steroid hormone receptor function, is increasingly recognized for roles beyond the cytosol. Its components are promising therapeutic targets and biomarkers for prostate cancer.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Steroid hormone receptors are vital transcription factors regulating numerous physiological processes.
  • The foldosome, comprising chaperone proteins, is essential for ligand binding to these receptors.
  • Recent findings reveal foldosome involvement in nuclear translocation and gene expression, expanding its known functions.

Purpose of the Study:

  • To review the impact of the foldosome on androgen receptor signaling.
  • To explore the potential of foldosome components as biomarkers and therapeutic targets in prostate cancer.

Main Methods:

  • Literature review of current research on foldosome components and steroid hormone receptors.
  • Focus on studies investigating androgen receptor signaling pathways.
  • Analysis of data linking foldosome dysregulation to cancer development.

Main Results:

  • The foldosome's role extends to nuclear translocation and target gene expression, not just ligand binding.
  • Dysregulation of foldosome components is implicated in various cancers, notably prostate cancer.
  • Androgen receptor signaling, a key target in prostate cancer, is significantly influenced by the foldosome.

Conclusions:

  • The foldosome is a critical regulator of androgen receptor signaling.
  • Foldosome components represent attractive therapeutic targets and potential biomarkers for prostate cancer management.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...